BELLEVUE, Wash., Jan. 11, 2010 (GLOBE NEWSWIRE) -- TapImmune, Inc. (OTCBB:TPIV) announced today President Denis Corin will be presenting at the OneMedPlace's Forum 2010, Emerging Company Finance Conference, on Wednesday, January 13, 2010, at 9:15 a.m. Pacific time (12:15 p.m. Eastern time). The conference is being held at the Sir Francis Drake Hotel in San Francisco.
About TapImmune Inc.
TapImmune Inc. is a biotechnology company specializing in the development of innovative cell based immunotherapeutics and vaccines in the areas of oncology and infectious disease. The Company's lead product candidate, the AdhTAP vaccine enhancer is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system. The Company is currently planning the development AdhTAP for the commencement of clinical manufacturing and toxicology studies. The Company is also developing a TAP based prophylactic vaccine which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times.
As a vaccine, our TAP technology is not only needed but could significantly improve the efficacy of many current prophylactic vaccines and enhance the creation of new ones in the fight against many pandemic infectious diseases. As a cancer therapy, our TAP vaccine alone or in combination with others could prove to be a key component of a more successful assault on cancer.
The TapImmune Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3877